A chemotherapy-free-based regimen of the TKI ponatinib combined with targeted immunotherapy showed significant benefits in ...

Electronic health records can help identify triggers for advance care planning that align with optimal timing windows, mainly ...

Rules that allow for this expanded scope without requiring physician collaboration vary by state. Currently in the US, 27 ...

A backlash against pandemic-era restrictions, online misinformation, and a lack of resources for healthcare have contributed ...

Intestinal ultrasound is highly acceptable and well tolerated by patients with inflammatory bowel disease, reflecting strong ...

The experimental drug neflamapimod reduced a key biomarker of neurodegeneration, which correlated with a slowing of cognitive ...

Over-the-counter medicines were the most frequent treatment choice for 16 symptoms, with the highest use for headaches (63.2% ...

The first-of-its kind gene therapy uses a patient’s skin cells to create sheets to treat the open wounds caused by the rare, ...

Cannabis hyperemesis prevalence rose sharply during the COVID-19 pandemic and remains elevated in the US, a study finds.

Novel biomarkers — thioredoxin and tetraspanin 30 — can identify angioinvasion in papillary thyroid cancer, enabling risk ...

In the phase 3 COBRA trial, the carfilzomib/lenalidomide/dexamethasone regimen shows significant improvements in PFS and other outcomes in newly diagnosed MM, including in patients at cytogenic risk.

Semaglutide, a GLP-1 receptor agonist (RA), was associated with a significantly lower risk for adult-onset epilepsy in patients with diabetes than other glucose-lowering drugs (GLDs). Notably, this ...